ChitogenX concludes enrolment for its US Phase I/II rotator cuff tear repair clinical trial
ChitogenX Inc (CSE:CHGX, OTCQB:CHNXF) said it has concluded the enrolment of 20 subjects in its US multi-site rotator cuff tear repair Phase I/II clinical...
Source: proactiveinvestors.com